Dr. Alexander Walter Chasnis, MD Physical Medicine & Rehabilitation - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 10315 Hamptons Park Dr, Huntersville, NC 28078 Phone: 704-323-2800 |
Latha Baddigam, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 16511 Northcross Dr Ste A, Huntersville, NC 28078 Phone: 704-896-3313 |
Dr. Edward Conrad Robles, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 10305 Hamptons Park Dr Ste 101, Huntersville, NC 28078 Phone: 704-316-5388 Fax: 704-316-1848 |
Jeneva Gatses, DPT Physical Medicine & Rehabilitation - Sports Medicine Medicare: Not Enrolled in Medicare Practice Location: 13759 Cinnabar Pl, Huntersville, NC 28078 Phone: 708-277-7567 |
Mrs. Tyler Ecker Naylor, A5299 Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 13620 Reese Blvd E Ste 130, Huntersville, NC 28078 Phone: 704-274-5795 Fax: 704-274-5750 |
Preeti Sailesh Panchang, M.D Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 10305 Hamptons Park Dr, Ste 101, Huntersville, NC 28078 Phone: 704-895-9838 Fax: 704-316-3083 |
News Archive
The stakes are high for the health law's future with the vote either sealing the measure's implementation or becoming its undoing. However, some of the changes it includes have already been internalized by the health care marketplace.
Laws to ban or curb drivers' use of cell phones and other handheld devices have greatly reduced the rate of fatalities for motorcyclists, according to a new study by faculty at Florida Atlantic University and the University of Miami.
A team of researchers from Sanford-Burnham Medical Research Institute (Sanford-Burnham) and SUNY Downstate Medical Center (SUNY Downstate) has found that deficiencies in hyaluronan, also known as hyaluronic acid or HA, can lead to spontaneous epileptic seizures.
Boehringer Ingelheim Ltd. today announces that Health Canada has granted approval of PRADAX (dabigatran etexilate), an oral anticoagulant for the prevention of stroke and systemic embolism in adults with atrial fibrillation in whom anticoagulation is appropriate. PRADAX is the first innovative drug approved in Canada in more than two decades to reduce the risk of stroke in Canadians with atrial fibrillation.
› Verified 4 days ago